Genfit SA  

(Public, EPA:GNFT)   Watch this stock  
Find more results for EPA:ALGFT
+2.80 (7.63%)
Oct 30 - Close
EPA real-time data - Disclaimer
Currency in EUR
Range 36.10 - 39.75
52 week 6.94 - 48.95
Open 36.51
Vol / Avg. 380,695.00/460,826.00
Mkt cap 923.05M
P/E     -
Div/yield     -
EPS -0.66
Shares 23.37M
Beta     -
Inst. own     -
Nov 4, 2014
Genfit SA at EBD Group BIO-Europe Conference - 9:30AM GMT+1 - Add to calendar
Oct 2, 2014
Genfit SA at CF&B Large & Midcap Event
Sep 17, 2014
Genfit SA at Kepler Cheuvreux Autumn Conference

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -153.70% -212.02%
Operating margin -158.05% -176.19%
EBITD margin - -165.87%
Return on average assets -29.70% -47.99%
Return on average equity -58.30% -120.92%
Employees 78 -
CDP Score - -


885 Avenue Eugene Avinee, Parc Eurasante
LOOS, 59120
+33-3-20164000 (Phone)
+33-3-20164001 (Fax)

Website links


Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The Company is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver, such as Nonalcoholic steatohepatitis (NASH) or the bowel, such as the inflammatory bowel disease. The Company�s research programs develop diversified pipeline of drug candidates, including GFT505, which completes a Phase 2b study in NASH. The Company�s facilities are located in France and the United States. The Company�s wholly owned subsidiaries include Genfit Corporation, located in Cambridge, the United States and Genfit Pharmaceuticals SAS.

Officers and directors

Xavier Guille Des Buttes Chairman of the Supervisory Board
Jean-Francois Mouney Chairman of the Management Board, Chief Executive Officer
Charles Woler Vice Chairman of the Supervisory Board
Raphael Darteil Chief Operating Officer, Executive Vice President, Member of the Management Board
Nathalie Huitorel Executive Vice President of Finance, Member of the Management Board
Bart Staels President of the Scientific Advisory Board, Member of the Management Board
Frederic Lobez Member of the Supervisory Board, Representative of Universite de Lille II
Philippe Moons Member of the Supervisory Board, Representative of Finorpa
Florence Sejourne Member of the Supervisory Board, Representative of Biotech Avenir
Philippe Traisnel MBA Independent Supervisory Board, Representative of CM-CIC Capital Finance